Everence Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,850
| Closed | -$115K | – | 928 |
|
|
2024
Q3 | $115K | Buy |
27,850
+7,420
| +36% | +$30.6K | 0.01% | 741 |
|
|
2024
Q2 | $158 | Hold |
20,430
| – | – | 0.01% | 714 |
|
|
2024
Q1 | $178 | Hold |
20,430
| – | – | 0.01% | 733 |
|
|
2023
Q4 | $234K | Hold |
20,430
| – | – | 0.02% | 654 |
|
|
2023
Q3 | $197 | Buy |
20,430
+10,340
| +102% | +$100 | 0.02% | 679 |
|
|
2023
Q2 | $110K | Hold |
10,090
| – | – | 0.01% | 714 |
|
|
2023
Q1 | $106 | Sell |
10,090
-34,960
| -78% | -$367 | 0.01% | 735 |
|
|
2022
Q4 | $558 | Sell |
45,050
-9,440
| -17% | -$117 | 0.05% | 336 |
|
|
2022
Q3 | $565K | Hold |
54,490
| – | – | 0.05% | 313 |
|
|
2022
Q2 | $628K | Buy |
+54,490
| New | +$628K | 0.06% | 272 |
|